Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs.

Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. 

Our products are first-in-class multifunctional peptides with high potential in many CNS disorders.

Biotechnology

Health Care

Life Sciences

Therapeutics

Axoltis Pharma

Axoltis Pharma's headquarters in Lyon, France

Description

People (4)

Yann Godfrin

Juliette Le Douce

Nicolas Rebergue

Gilles Avenard

Jobs